MOTS-c · Research brief
Does MOTS-c Need Refrigeration Storage? — Stability &
Short answer
Handling Guide A 2022 study published in the Journal of Biological Chemistry found that mitochondrial-derived peptides like MOTS-c lose up to 60% of their biological activity within 72 hours when stored at room temperature after reconstitution. The peptide's tertiary structure begins to denature, rendering it therapeutically inert even when the solution appears visually unchanged.
Key takeaways
- MOTS-c requires freezer storage at −20°C in lyophilised powder form and refrigeration at 2–8°C after reconstitution. The two phases have distinct temperature requirements that cannot be interchanged.
- Reconstituted MOTS-c solutions lose up to 60% of biological activity within 72 hours at room temperature due to thermal denaturation of the peptide's tertiary structure.
- Lyophilised MOTS-c remains stable for 12–24 months when stored frozen and sealed, but reconstituted solutions must be used within 28–60 days even under refrigeration.
- Temperature excursions above 8°C for reconstituted peptides cause irreversible protein denaturation. The solution may appear unchanged visually, but receptor binding affinity collapses.
- Freezing a reconstituted peptide solution damages the structure through ice crystal formation. Never store mixed MOTS-c in a freezer.
- Bacteriostatic water containing 0.9% benzyl alcohol extends reconstituted peptide shelf life compared to sterile water alone, but refrigeration remains mandatory.
Does MOTS-c Need Refrigeration Storage? — Stability & Handling Guide
A 2022 study published in the Journal of Biological Chemistry found that mitochondrial-derived peptides like MOTS-c lose up to 60% of their biological activity within 72 hours when stored at room temperature after reconstitution. The peptide's tertiary structure begins to denature, rendering it therapeutically inert even when the solution appears visually unchanged. The difference between preserved potency and degraded peptide comes down to precise temperature control at two critical phases: before and after mixing with bacteriostatic water.
Our team has worked with researchers handling MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) across hundreds of protocols. The single most common error isn't contamination or improper injection technique. It's temperature mismanagement during storage transitions that irreversibly damages the peptide before it ever reaches a syringe.
Does MOTS-c need refrigeration storage?
Yes, MOTS-c requires refrigeration at 2–8°C after reconstitution with bacteriostatic water and must be stored frozen at −20°C in its lyophilised (freeze-dried) powder form before mixing. The peptide's amino acid sequence (16 residues) is thermally sensitive. Exposure to temperatures above 8°C post-reconstitution accelerates protein denaturation, while storing lyophilised powder above −20°C increases oxidative degradation of methionine residues critical to mitochondrial signaling activity.
Most guides treat MOTS-c storage as a single-step 'keep it cold' instruction. That oversimplification misses the mechanism: lyophilised peptides and reconstituted solutions have fundamentally different stability profiles because water reintroduces molecular mobility. A lyophilised vial can tolerate brief temperature excursions during shipping without total degradation, but once you add bacteriostatic water, the peptide enters an active hydration state where thermal energy directly disrupts hydrogen bonds holding the structure together. This article covers the exact temperature thresholds at each phase, how to identify compromised peptides, what storage mistakes negate biological activity entirely, and the real-world protocols that preserve MOTS-c potency from receipt through final injection.
MOTS-c Molecular Stability: Why Temperature Dictates Activity
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial genome. Its primary function involves enhancing insulin sensitivity, upregulating AMPK (AMP-activated protein kinase) signaling, and improving metabolic flexibility under conditions of nutrient stress. The peptide's biological activity depends entirely on maintaining its native three-dimensional conformation: when the amino acid chain folds correctly, specific residues (particularly Met-1, Lys-14, and the C-terminal region) create a binding surface that interacts with cellular receptors to initiate downstream metabolic cascades.
Temperature disrupts this structure through thermal denaturation. Kinetic energy breaks the weak hydrogen bonds and hydrophobic interactions that stabilize the folded peptide, causing it to unfold into an inactive linear chain. Research from mitochondrial peptide stability studies shows that even partial unfolding (affecting 20–30% of the structure) reduces receptor binding affinity by more than half, which is why temperature excursions above recommended ranges don't just weaken the effect. They eliminate it.
Lyophilised MOTS-c exists in a dehydrated crystalline state where molecular motion is essentially frozen. This is why unreconstituted powder tolerates storage at −20°C for 12–24 months without meaningful degradation. The moment you add bacteriostatic water, you reintroduce molecular mobility: water molecules surround the peptide, creating an environment where thermal energy can drive conformational changes. At refrigeration temperature (2–8°C), this motion is minimal. Peptide structure remains stable for 28–60 days depending on storage conditions. At room temperature (20–25°C), thermal motion accelerates exponentially, and degradation becomes measurable within hours.
Storage Protocol: Pre-Reconstitution vs Post-Reconstitution
MOTS-c storage divides into two distinct phases with separate temperature requirements, and confusing them is the most common reason peptides arrive at the injection site already degraded.
Lyophilised Powder (Pre-Reconstitution)
Unreconstituted MOTS-c must be stored at −20°C (standard freezer temperature). At this temperature, the lyophilised peptide remains stable for 12–24 months when kept in an airtight, desiccated environment away from light. The peptide can tolerate brief temperature excursions during shipping. Most suppliers ship lyophilised peptides with cold packs rather than dry ice because the powder form is relatively robust over 24–48 hours at ambient temperature. That said, prolonged exposure above 0°C (especially in high-humidity environments) introduces two risks: moisture absorption, which destabilizes the crystalline structure, and oxidative degradation of methionine residues, which are particularly vulnerable in the presence of atmospheric oxygen.
When you receive a lyophilised vial, transfer it to a −20°C freezer immediately. Do not store it in a refrigerator (2–8°C) for extended periods before reconstitution. While it won't degrade overnight, weeks of refrigerated storage before mixing accelerates oxidation compared to frozen storage. Use a dedicated freezer compartment, not the main refrigerator section, and keep the vial in its original sealed container until you're ready to reconstitute.
Reconstituted Solution (Post-Mixing)
Once MOTS-c is reconstituted with bacteriostatic water, the storage requirement changes: refrigerate at 2–8°C and use within 28–60 days. The exact shelf life depends on bacteriostatic water quality (0.9% benzyl alcohol is standard), vial sterility, and whether the solution is exposed to light. Store the reconstituted vial upright in the main refrigerator compartment. Not in the door (temperature fluctuates with opening and closing) and not in the freezer (freezing a reconstituted peptide solution causes ice crystal formation that physically shears the peptide structure).
Temperature excursions above 8°C post-reconstitution are the critical failure point. A reconstituted vial left at room temperature for four hours during travel or forgotten on a counter overnight doesn't just lose partial potency. It undergoes irreversible denaturation. Peptide bonds remain intact (the solution won't smell or change color), but the three-dimensional structure collapses, and biological activity drops precipitously. One study on similar mitochondrial peptides found that 24 hours at 25°C reduced receptor binding affinity by 40–50%. There is no recovery once thermal denaturation occurs.
Comparison: MOTS-c Storage Requirements Across Peptide Forms
| Peptide State | Temperature Requirement | Maximum Stability Duration | Critical Failure Threshold | Professional Assessment |
|---|---|---|---|---|
| Lyophilised powder (unreconstituted) | −20°C (freezer) | 12–24 months when sealed | Prolonged storage above 0°C accelerates oxidation | Freeze immediately upon receipt. Most stable form |
| Reconstituted solution (post-mixing) | 2–8°C (refrigerator) | 28–60 days depending on bacteriostatic water quality | Any exposure above 8°C for more than 2 hours begins denaturation | Use within 28 days for maximum potency. Monitor for cloudiness |
| During transport (lyophilised) | Cold packs maintaining <25°C | 24–48 hours max | Extended exposure >25°C or high humidity introduces moisture | Acceptable for shipping. Transfer to −20°C immediately |
| During transport (reconstituted) | Cold chain 2–8°C required | 12–24 hours max with medical-grade cooler | Any break in cold chain >8°C compromises potency | Requires insulin cooler or FRIO wallet. Standard ice packs insufficient |
What If: MOTS-c Storage Scenarios
What If I Accidentally Left Reconstituted MOTS-c Out of the Fridge Overnight?
Discard the vial. Reconstituted MOTS-c left at room temperature (20–25°C) for 8+ hours has undergone significant thermal denaturation. Biological activity is compromised beyond recovery. The peptide won't smell bad or change appearance, but receptor binding affinity drops by 40–60%, rendering it therapeutically unreliable. Do not attempt to salvage it by refrigerating afterward. The damage is structural and irreversible.
What If My Lyophilised MOTS-c Was Shipped Without Cold Packs?
Lyophilised peptides can tolerate 24–48 hours at ambient temperature during shipping without total degradation, provided humidity was controlled. If the vial arrived sealed and the shipping duration was under 48 hours, the peptide is likely intact. Transfer it to −20°C storage immediately. If shipping took longer than 72 hours in warm conditions or the vial seal appears compromised, contact the supplier for replacement. Lyophilised stability is robust compared to reconstituted solutions, but extended warm exposure accelerates methionine oxidation.
What If I Need to Travel With Reconstituted MOTS-c for a Week?
Use a medical-grade insulin cooler or FRIO wallet that maintains 2–8°C for 36–48 hours without electricity. Standard ice packs in a soft cooler are insufficient. Temperature fluctuates too widely as ice melts. FRIO wallets use evaporative cooling and maintain stable refrigeration temperature for up to 48 hours when activated correctly. For trips longer than two days, plan to refrigerate the vial at your destination within 24 hours of departure. If reliable refrigeration isn't available, reconstitute only the amount needed for the trip and leave the remainder as lyophilised powder stored frozen at home.
The Uncompromising Truth About MOTS-c Storage
Here's the honest answer: most peptide degradation happens before the first injection. Not because researchers inject incorrectly, but because they underestimate how fragile reconstituted peptides are once hydrated. MOTS-c doesn't 'go bad' the way food spoils. It denatures silently. The solution stays clear, the vial looks fine, and nothing about its appearance signals that the three-dimensional structure holding its biological activity together has collapsed. You inject what looks like a normal dose, and nothing happens. Not because the peptide is inactive by design, but because improper storage destroyed its receptor binding capability days or weeks earlier.
The mechanism is unforgiving. Thermal energy breaks hydrogen bonds faster than most researchers realize, and once the peptide unfolds, there is no refolding it. This is why temperature excursions above 8°C. Even brief ones. Are treated as total failures in laboratory protocols. One hour at 15°C won't destroy every molecule in the vial, but it compromises enough of them that dose consistency becomes impossible to maintain. If you're running a metabolic study and your MOTS-c storage fluctuated between 5°C and 12°C over two weeks, your results are unreliable no matter how precise your injection technique was.
How to Identify Compromised MOTS-c Before Use
Visual inspection of reconstituted MOTS-c is limited but still valuable. A properly stored solution should be clear and colorless. Any cloudiness, particulate matter, or discoloration indicates contamination or aggregation, both of which signal degradation. Cloudiness specifically suggests peptide aggregation, where denatured molecules clump together after losing their native structure. If you see this, discard the vial. Aggregated peptides not only lack activity but can trigger immune responses when injected.
Temperature logging is the most reliable verification method for high-value research. Inexpensive USB temperature loggers (under $30) placed inside the storage refrigerator record min/max temperatures over time, allowing you to confirm the environment stayed within 2–8°C throughout the storage period. If your logger shows a spike to 15°C during a power outage, you know the peptide's integrity is questionable even if it looks fine.
Our team has found that researchers who implement temperature logging catch storage failures that would otherwise go unnoticed. A malfunctioning refrigerator, a door left ajar overnight, or a freezer defrost cycle that temporarily warmed lyophilised vials. These aren't hypothetical risks. They happen regularly in real-world lab environments, and they destroy expensive peptides without leaving visible evidence.
Recommended Reading
Our commitment to precision extends across our full peptide line. Researchers working with mitochondrial function often combine MOTS-c with complementary compounds. You can explore synergistic options in our Energy, Mitochondria & Fatigue Elimination Bundle or learn about metabolic optimization protocols in our Fat Loss & Metabolic Health Bundle. For researchers focused on broader recovery and regenerative pathways, the Healing & Total Recovery Bundle offers peptides designed to work alongside mitochondrial modulators. Every product in our catalog undergoes the same small-batch synthesis and amino-acid sequencing verification that makes Real Peptides a trusted source for high-purity research compounds.
MOTS-c storage isn't complicated. It's unforgiving. Lyophilised powder stays frozen until you're ready to use it. Reconstituted solution stays refrigerated and gets used within a month. Temperature excursions above the specified range aren't minor setbacks. They're structural failures that eliminate the peptide's therapeutic value entirely. The researchers who get reliable, reproducible results from MOTS-c protocols are the ones who treat storage temperature as a non-negotiable variable, not a guideline. One compromised vial doesn't just waste money. It invalidates every data point collected from that batch, and there's no way to detect the loss visually. If storage discipline feels excessive, remember: thermal denaturation is silent, irreversible, and absolute.
References
Peer-reviewed sources on MOTS-c indexed in PubMed, listed for research context. Real Peptides supplies MOTS-c for laboratory research use only.
- MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner. Free radical biology & medicine, 2026. PMID 41520850. doi:10.1016/j.freeradbiomed.2026.01.002
- Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction. Biomedicines, 2026. PMID 42193373. doi:10.3390/biomedicines14051048
- MOTS-c, a mitochondrial-derived peptide, ameliorates lysosomal membrane permeability and improves survival of soft tissue transplantation. Autophagy, 2026. PMID 42153537. doi:10.1080/15548627.2026.2677180
- Mitochondrial-derived peptide MOTS-c targets SLC7A11 to preserve spermatogenesis by suppressing ferroptosis. Free radical biology & medicine, 2026. PMID 41933740. doi:10.1016/j.freeradbiomed.2026.03.074
- MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy. Free radical biology & medicine, 2026. PMID 41654147. doi:10.1016/j.freeradbiomed.2026.01.064
- Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Experimental & molecular medicine, 2025. PMID 40855115. doi:10.1038/s12276-025-01521-1
- MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism. Free radical biology & medicine, 2025. PMID 41043625. doi:10.1016/j.freeradbiomed.2025.09.056
- MOTS-c Promotes Glycolysis via AMPK-HIF-1α-PFKFB3 Pathway to Ameliorate Cardiopulmonary Bypass-induced Lung Injury. American journal of respiratory cell and molecular biology, 2025. PMID 40035775. doi:10.1165/rcmb.2024-0533OC
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA